業績
Achievements
- トップ >
- 2019年度
2019年度
| No. | |
|---|---|
| 1 | Non-motor outcomes depend on location of neurostimulation in Parkinson's disease／Petry-Schmelzer JN, Krause M, Dembek TA, Horn A, Evans J, Ashkan K, Rizos A, Silverdale M, Schumacher W, Sack C, Loehrer PA, Fink GR, Fonoff ET, Martinez-Martin P, Antonini A, Barbe MT, Visser-Vandewalle V, Ray-Chaudhuri K, Timmermann L, Dafsari HS; EUROPAR and the IPMDS Non-Motor PD Study Group. Brain. 2019 Nov 1;142(11):3592-3604 |
| 2 | Non-motor symptoms depending on motor severity in Japanese patients with Parkinson's disease: A multicenter cross-sectional study／Toyama M, Okuma Y, Yamamoto M, Kashihara K, Yoshida K, Saiki H, Maeda T, Tsuboi Y, Takahashi Y, Nakayama T. J Neurol Sci. 2019 Dec 19;412:116641 |
| 3 | Explant Culture of the Embryonic Mouse Spinal Cord and Gene Transfer by ex vivo Electroporation／Kinoshita-Kawada M, Hasegawa H, Hongu T, Yanagi S, Kanaho Y, Masai I, Mishima T, Chen X, Tsuboi1 Y, Rao Y, Yuasa-Kawada J, and Wu JY. Bio-protocol 2019; 9(18): e3373 |
| 4 | Cerebrospinal fluid CXCL10 as a candidate surrogate marker for HTLV-1-associated myelopathy/tropical spastic paraparesis／Tamaki K, Sato T, Tsugawa J, Fujioka S, Yagishita N, Araya N, Yamauchi J, Lucia Coler-Reilly A, Nagasaka M, Hasegawa Y, Yamano Y, Tsuboi T. Front Microbiol. 2019 Sep 11;10:2110 |
| 5 | Effects of Plasmalogen on Patients with Moderate-to-Severe Alzheimer’s Disease and Blood Plasmalogen Changes: A Multi-Center, Open-Label Study／Fujino T, Yamada T, Mawatari S, Shinfuku N, Tsuboi Y, Wakana C, Kono S. Journal of Alzheimer’s Disease & Parkinsonism in press 2019 |
| 6 | A new therapeutic strategy with istradefylline for postural deformities in Parkinson's disease／Fujioka S, Yoshida R, Nose K, Hayashi Y, Mishima T, Fukae J, Kitano K, Kikuchi H, Tsuboi Y. Neurol Neurochir Pol. 2019 Aug 23 |
| 7 | Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease／Sone J, Mitsuhashi S, Fujita A, Mizuguchi T, Hamanaka K, Mori K, Koike H, Hashiguchi A, Takashima H, Sugiyama H, Kohno Y, Takiyama Y, Maeda K, Doi H, Koyano S, Takeuchi H, Kawamoto M, Kohara N, Ando T, Ieda T, Kita Y, Kokubun N, Tsuboi Y, Katoh K, Kino Y, Katsuno M, Iwasaki Y, Yoshida M, Tanaka F, Suzuki IK, Frith MC, Matsumoto N, Sobue G. Nat Genet. 2019 Jul 22 |
| 8 | A crucial role for Arf6 in the response of commissural axons to Slit／Kinoshita-Kawada M, Hasegawa H, Hongu T, Yanagi S, Kanaho Y, Masai I, Mishima T, Chen X, Tsuboi Y, Rao Y, Yuasa-Kawada J, Wu JY. Development. 2019 Feb 4;146(3) |
| 9 | p150glued deficiency impairs effective fusion between autophagosomes and lysosomes due to their redistribution to the cell periphery／Ishikawa KI, Saiki S, Furuya N, Imamichi Y, Tsuboi Y, Hattori N. Neurosci Lett. 2019 Jan 18;690:181-187 |
| 10 | Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source／Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-SPECT ESUS Steering Committee and Investigators. N Engl J Med. 2019 May 16;380(20):1906-1917 |
| 11 | Impact of cerebral large-artery disease and blood flow in the posterior cerebral artery territory on cognitive function／Watanabe J, Ogata T, Tsuboi Y, Inoue T. J Neurol Sci. 2019;402:7-11 |
| 12 | Increased Plasma VEGF Levels in Patients with Cerebral Large Artery Disease Are Associated with Cerebral Microbleeds／Ogata T, Dohgu S, Takano K, Inoue T, Arima H, Takata F, Kataoka Y, Tsuboi Y. Cerebrovasc Dis Extra. 2019;9(1):25-30 |
| 13 | Sensitivity and specificity of cardiac 123I-MIBG scintigraphy for diagnosis of early-phase Parkinson's disease／Kawazoe M, Arima H, Maeda T, Tsuji M, Mishima T, Fujioka S, Tsugawa J, Tsuboi Y. J Neurol Sci. 2019 Jul 24;407:116409 |
| 14 | Serum B-type natriuretic peptide level and timing of its measurement as a predictor of acute ischemic stroke outcome／Fukuhara K, Ogata T, Takeshita S, Tsuboi Y. eNeurologicalSci. 2019 Dec 2;18:100217 |
| 15 | Feeding-produced subchronic high plasma levels of uric acid improve behavioral dysfunction in 6-hydroxydopamine-induced mouse model of Parkinson's disease／Nakashima A, Yamauchi A, Matsumoto J, Dohgu S, Takata F, Koga M, Fukae J, Tsuboi Y, Kataoka Y. Behav Pharmacol. 2019 Feb;30(1):89-94 |
| 16 | パーキンソン病患者における日中身体活動量の活動強度別の特徴および歩数との関連性／長城晃一、池永昌弘、藤岡伸助、坪井義夫．作業療法 2019; 37: 137-144 |
| 17 | 若年性脳梗塞の原因についての検討／有富わかな、緒方利安、坪井義夫． Journal of Achievement for Medical Students 2019; 2: 12-25 |
| 18 | The Comparison of Clinical Findings and Treatment Between Unilateral and Bilateral Vertebral Artery Dissection／Takahara M, Ogata T, Abe H, et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2019;28:1192-9 |
| 19 | Efficacy, Safety, and Tolerability of Switching from Oral Cholinesterase Inhibitors to Rivastigmine Transdermal Patch with 1-Step Titration in Patients with Mild to Moderate Alzheimer's Disease: A 24-Week, Open-Label, Multicenter Study in Japan／Ueda K, Katayama S, Arai T, Furuta N, Ikebe S, Ishida Y, Kanaya K, Ouma S, Sakurai H, Sugitani M, Takahashi M, Tanaka T, Tsuno N, Wakutani Y, Shekhawat A, Das Gupta A, Kiyose K, Toriyama K, Nakamura Y. Dement Geriatr Cogn Dis Extra. 2019 Aug 15;9(2) |
| No. | |
|---|---|
| 1 | Posterior Interosseous Nerve Palsy Caused by A Ganglion／Yokote A, Fujioka S, Ishiko T, Tsuboi Y. Intern Med. 2019 Feb 1 |
| 2 | Juvenile Muscular Atrophy of the Proximal Upper Extremity as So-Called Proximal-Type Hirayama Disease: Case Report and Review of the Literature／Yokote A, Fukuhara K, Tsugawa J, Tsuboi Y. Case Reports in Neurology 2019; 11:106–111 |